Biotech

All Articles

Kairos goes public with $6M IPO to money tests of cancer cells drug

.Along with a triad of biotechs striking the Nasdaq on Friday, it was effortless to miss out on a sm...

Vaccine and Keytruda combination helpful in squamous cell cancer

.Immune system checkpoint inhibitors are the superheroes of cancer cells therapy. Medicines like Bri...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings an...

Regeneron's Opdualag opponent reveals 57% reaction fee

.Regeneron is back with long-term consequence for its own LAG-3 prevention and PD-1 prevention combo...

AstraZeneca articles information on in-house rivals to AbbVie, Pfizer ADCs

.AstraZeneca has shared a very early examine the performance of its own internal antibody-drug conju...

iTeos- GSK's TIGIT celebrity reveals meaningful enhancement

.After announcing a phase 3 launch based upon good midstage outcomes, iTeos as well as GSK are actua...

More joint FDA can increase uncommon ailment R&ampD: record

.The FDA needs to be extra open as well as joint to unleash a surge in approvals of uncommon health ...

Zenas, MBX, Bicara head to Nasdaq in very hot day for biotech IPOs

.It is actually an uncommonly busy Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara The...

Atea's COVID antiviral stops working to stop hospital stays in stage 3

.Atea Pharmaceuticals' antiviral has actually stopped working yet another COVID-19 trial, but the bi...

Neurocrine's offer to save mental illness prospect stops working

.Neurocrine Biosciences' schizophrenia course pivot has actually neglected. The biotech was actually...